Tumor Localization of 16[beta]-^sup 18^F-Fluoro-5[alpha]-Dihydrotestosterone Versus ^sup 18^F-FDG in Patients with Progressive, Metastatic Prostate Cancer

From: The Journal of Nuclear Medicine | Date: March 1, 2004| Author: Larson, Steven M; Morris, Michael; Gunther, Ilonka; Beattie, Brad; Et al | Copyright information

This trial was an initial assessment of the feasibility, in vivo targeting, and biokinetics of 16[beta]-^sup 18^F-fluoro-5[alpha]-dihydrotestosterone (^sup 18^F-FDHT) PET in patients with metastatic prostate cancer to assess androgen receptor expression. Methods: Seven patients with progressive clinically metastatic prostate cancer underwent ^sup 18^F-FDG and ^sup 18^F-FDHT PET scans in addition to conventional imaging methods. Three patients had their studies repeated 1 mo later, 2 while on ...

Related newspaper, magazine, and journal articles from HighBeam Research

PET Imaging of GRP Receptor Expression in Prostate Cancer
The Journal of Nuclear Medicine ; An the United States alone, 1 in 6 men will be diagnosed with prostate cancer over the course of their lifetimes, with 31,000 dying each year from the disease. Imaging prostate cancer remains a major challenge in nuclear medicine. ^sup 18^F-FDG, the most commonly used radiotracer for the detection
1-^sup 11^C-Acetate Kinetics of Prostate Cancer
The Journal of Nuclear Medicine ; ^sup 18^F-FDG is in widespread use in cancer imaging but has limited utility in staging and monitoring of prostate cancer. 1-^sup 11^C-Labeled acetate, a substrate for the citric acid cycle, is superior. The kinetics of prostate tumors were investigated. Methods: Ten patients with primary prostate
(11)C-acetate PET imaging of prostate cancer
The Journal of Nuclear Medicine ; ^sup 11^C-Acetate can act as a probe of tissue metabolism through entry into catabolic or anabolic metabolic pathways as mediated by acetyl-coenzyme A. The uptake of ^sup 11^C-acetate in prostate cancer was investigated to determine whether this tracer has potential in tumor identification.
PET imaging of prostate cancer using carbon-11-choline
The Journal of Nuclear Medicine ; Prostate cancer is difficult to visualize using current techniques. Recently, ^sup 31^P magnetic resonance spectroscopy has revealed that the tumor, in general, is characterized by an increased uptake of choline into the cell to meet increased synthesis of phosphatidylcholine, an important cell
Development of (18)F-fluoroethylcholine for cancer imaging with PET: Synthesis, biochemistry, and prostate cancer imaging
The Journal of Nuclear Medicine ; The effectiveness of ^sup 11^C-choline PET in detecting various cancers, including prostate cancer, is well established. This study was aimed at developing an ^sup 18^F-substituted choline analog, ^sup 18^F-fluoroethylcholine (FECh), as a tracer of cancer detection. Methods: No-carrier-added ^sup